Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
[PMID: 19080238] PubMed record related to this compound for laboratory literature review
Related articles Related Qustion What are the side effects of CJC1295
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
Midday administration (46 hours post 5-Amino-1MQ): MOTS-c 510mg subcutaneously
The injections can cause a little bruising in the surrounding areas along with itching and discomfort
